Methyl 4-[4-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]ethyl]piperazin-1-yl]benzoate
C26H27Cl2N3O3 — CID 155401626
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 4-[4-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]ethyl]piperazin-1-yl]benzoate
Methyl 4-[4-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]ethyl]piperazin-1-yl]benzoate (PubChem CID 155401626) has the molecular formula C26H27Cl2N3O3 and a molecular weight of 500.43 g/mol. Its IUPAC name is methyl 4-[4-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]ethyl]piperazin-1-yl]benzoate.
Molecular Properties
| Compound Name | Methyl 4-[4-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]ethyl]piperazin-1-yl]benzoate |
|---|---|
| PubChem CID | 155401626 |
| Molecular Formula | C26H27Cl2N3O3 |
| Molecular Weight | 500.43 g/mol |
| Exact Mass | 499.14 |
| IUPAC Name | methyl 4-[4-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]ethyl]piperazin-1-yl]benzoate |
| SMILES | COC(=O)c1ccc(N2CCN(CCc3c(-c4c(Cl)cccc4Cl)noc3C3CC3)CC2)cc1 |
| InChI | InChI=1S/C26H27Cl2N3O3/c1-33-26(32)18-7-9-19(10-8-18)31-15-13-30(14-16-31)12-11-20-24(29-34-25(20)17-5-6-17)23-21(27)3-2-4-22(23)28/h2-4,7-10,17H,5-6,11-16H2,1H3 |
| InChIKey | FCAMUODFIUFBML-UHFFFAOYSA-N |
| XLogP | 5.68 |
| TPSA | 58.81 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 500.43 |
| LogP ≤ 5 | 5.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155401626 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.